A new study from the University of California, San Francisco found that older adults with vitamin B12 levels considered normal by current health guidelines can still show measurable signs of brain damage and slower thinking. The findings raise questions about whether the standard cutoff for B12 deficiency is set too low to protect the aging brain.
According to Science Daily, researchers enrolled 231 healthy participants through the Brain Aging Network for Cognitive Health study at UCSF. Their average age was 71. None had dementia or mild cognitive impairment. Their average blood B12 level was 414.8 pmol/L, well above the U.S. minimum cutoff of 148 pmol/L. Yet even within that healthy range, participants with lower active B12 levels showed signs of slower thinking, delayed visual processing, and more visible injury to the brain's white matter.
White matter is made up of nerve fibers that allow different regions of the brain to communicate with each other. Damage to white matter has been linked to cognitive problems and is visible on brain scans.
The study was published in the journal Annals of Neurology. Senior author Ari J. Green, MD, of the UCSF Departments of Neurology and Ophthalmology and the Weill Institute for Neurosciences, led the work. Rather than relying only on total B12 levels in the blood, the researchers focused on measurements of biologically active B12, which more directly reflects how much of the vitamin the body is actually using.
Green and his colleagues said the results point to a possible gap in how B12 deficiency is currently defined. The minimum threshold used in standard guidelines may not catch early changes in the nervous system before symptoms become obvious.
"Previous studies that defined healthy amounts of B12 may have missed subtle functional manifestations of high or low levels that can affect people without causing overt symptoms," Green said. "Revisiting the definition of B12 deficiency to incorporate functional biomarkers could lead to earlier intervention and prevention of cognitive decline."
Vitamin B12 plays a central role in the body's ability to make DNA, red blood cells, and healthy nerve tissue. Clear deficiencies of the vitamin are commonly associated with a type of anemia. But the new research suggests the effects on the brain may begin earlier and more quietly than current guidelines account for.
The UCSF team said their findings call attention to a broader issue in how nutritional standards are set. Defining deficiency based only on avoiding obvious disease may not be the same as defining the level needed to keep the brain functioning well into old age. The researchers said incorporating functional markers, such as measures of how well the nervous system is actually performing, could give doctors a more accurate picture of whether a patient's B12 status is truly adequate.
The study adds to a growing body of research suggesting that nutritional thresholds established decades ago may need to be reexamined in light of newer tools for detecting subtle neurological changes.
